ERIC SCHAFER to Antineoplastic Agents
This is a "connection" page, showing publications ERIC SCHAFER has written about Antineoplastic Agents.
Connection Strength
0.349
-
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatr Blood Cancer. 2018 08; 65(8):e27066.
Score: 0.307
-
Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant. Pediatr Blood Cancer. 2009 Dec; 53(6):1127-9.
Score: 0.043